MedPath

Effect of a Tablet-administered Educational Video on Patients´ Knowledge on Osteoporosis and Treatment

Not Applicable
Completed
Conditions
Osteoporosis
Interventions
Behavioral: Educational video
Registration Number
NCT02445664
Lead Sponsor
University of Southern Denmark
Brief Summary

Osteoporosis is a highly prevalent disease in which non-adherence is a well-recognized problem. Non-adherence may be due to patients´ lack of knowledge, understanding, and involvement. In this study the investigators aimed to determine the effect of an educational video displayed on a tablet-device. The investigators hypothesized that an educational video would increase patients´ knowledge on osteoporosis and treatment at a two week follow up.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
67
Inclusion Criteria
  • Scheduled for at DXA scan at the osteoporosis clinic
  • Currently on once-weekly alendronate treatment
  • Informed consent
Exclusion Criteria
  • Patients that do not understand Danish
  • Patients having hearing impairments (unable to hear the video)
  • Patients having visual impairments (unable to watch the video)
  • Patients diagnosed with dementia
  • Patients unable to give written informed consent.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Video interventionEducational videoA tablet-administered educational video (10 minutes duration).
Primary Outcome Measures
NameTimeMethod
Change in knowledge scoreBaseline and 2-week follow up
Secondary Outcome Measures
NameTimeMethod
Change in "understandability of the information" score, as indicated by participants response to questionnaire.Baseline and 2-week follow up

Measured on a scale from 1-10

Change in "satisfaction with the amount of information" score, as indicated by participant response to questionnaire.Baseline and 2-week follow up

Measured on a scale from 1-10

Change in "confidence to treatment" score, as indicated by participant response to questionnaire.Baseline and 2-week follow up

Measured on a scale from 1-10

© Copyright 2025. All Rights Reserved by MedPath